Phenotypic Resistance to Antibiotics
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
The development of antibiotic resistance is usually associated with genetic changes, either to the acquisition of resistance genes, or to mutations in elements relevant for the activity of the antibiotic. However, in some situations resistance can be achieved without any genetic alteration; this is called phenotypic resistance. Non-inherited resistance is associated to specific processes such as growth in biofilms, a stationary growth phase or persistence. These situations might occur during infection but they are not usually considered in classical susceptibility tests at the clinical microbiology laboratories. Recent work has also shown that the susceptibility to antibiotics is highly dependent on the bacterial metabolism and that global metabolic regulators can modulate this phenotype. This modulation includes situations in which bacteria can be more resistant or more susceptible to antibiotics. Understanding these processes will thus help in establishing novel therapeutic approaches based on the actual susceptibility shown by bacteria during infection, which might differ from that determined in the laboratory. In this review, we discuss different examples of phenotypic resistance and the mechanisms that regulate the crosstalk between bacterial metabolism and the susceptibility to antibiotics. Finally, information on strategies currently under development for diminishing the phenotypic resistance to antibiotics of bacterial pathogens is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“By contrast, antifungal tolerance involves the earlier appearance of a subpopulation of cells that continue to grow in the presence of drug and, unlike “phenotypic resistance” described for bacteria 75 , is not dependent upon growth phase or cell density.”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Although most studies on bacterial susceptibility to antibiotics are performed using bacteria growing planktonically, microorganisms can grow forming biofilms when they are attached to a surface [32–35].”
BackgroundBacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143 · cited 1×
“Although most studies on bacterial susceptibility to antibiotics are performed using bacteria growing planktonically, microorganisms can grow forming biofilms when they are attached to a surface [32–35].”
BackgroundAntibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208 · cited 1×
“that are being developed to be used in the frame of novel anti-infective therapeutic strategies [71].”
BackgroundAntibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225 · cited 1×
“It has been then suggested that the use of DNase, which can break the biofilm matrix, may increase biofilm susceptibility to antibiotics [57].”
BackgroundBacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 1×
“emerges as the consequence of the inherent bistability of growing cells, from normal to persisters [121].”
BackgroundUnderstanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundLewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858 · cited 1×
“However, the situation is more complex [125], with a number of global regulators and metabolic enzymes involved in the process [126,127].”
BackgroundSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundThree Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682 · cited 1×
“different, including antibiotics [85–90].”
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
Kulp, A., & Kuehn, M. J. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.091208.073413 · Cited by 1,533 · cited 1×
“Among the roles that OMVs might play, it has been suggested that they are involved in secretion, intercellular signal trafficking and in bacterial survival-related functions [74].”
BackgroundMultidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522 · cited 1×
“Together with their high conservation, this suggests that efflux pumps have important roles for the bacterial physiology in addition to being antibiotic resistance determinants [89,90].”
BackgroundCrystal structures explain functional properties of two E. coli porins
Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., Jansonius, J. N., & Rosenbusch, J. P. (1992) · Nature · doi:10.1038/358727a0 · Cited by 1,520 · cited 1×
“with low osmolarity and temperature, whereas OmpC is the prevailing porin when bacteria are growing under conditions of high osmolarity and high temperature, like for example when they are colonizing a nutrient-rich animal gut [76].”
BackgroundAttenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422 · cited 1×
“aeruginosa infections [135,136].”
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundAminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321 · cited 1×
“bacterial populations [44,45], suggesting that antibiotics can induce transient, non-specific resistance to themselves.”
BackgroundTREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178 · cited 1×
“Persistence to antibiotic treatment has been described for several different bacterial species, and consists (Figure 1) on a situation in which a subpopulation of the bulk of bacteria under treatment presents a refractory state to the action of antibiotics [121–123].”
BackgroundThe challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042 · cited 1×
“tuberculosis cells are resistant to isoniazid, but susceptible to metronidazol [29–31].”
BackgroundMetabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025 · cited 2×
“based strategies for fighting persistent cells [19].”
BackgroundPseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundWalters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988 · cited 1×
“However, this would be just a part of the problem [50]; in several occasions the speed in the”
BackgroundEfflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939 · cited 2×
“Consequently, changes in bacterial permeability may affect the susceptibility to antibiotics [62,63].”
BackgroundAdaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892 · cited 2×
“Consequently, changes in bacterial permeability may affect the susceptibility to antibiotics [62,63].”
BackgroundSpecialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 856 · cited 1×
“can render non-uniform bacterial populations in which those cells containing high levels of toxin arrest their growth for long periods of time [39,130,131].”
BackgroundMultidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804 · cited 1×
“can render non-uniform bacterial populations in which those cells containing high levels of toxin arrest their growth for long periods of time [39,130,131].”
BackgroundCiprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782 · cited 3×
“For instance, quinolones can induce persistence in E. coli through the SOS-mediated induction of the toxin TisB [132] and intracellular pathogens can present nondividing, persistent, subpopulations when growing inside their host cells [133].”
BackgroundTHE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)
Kahan, F. M., Kahan, J. S., Cassidy, P. J., & Kropp, H. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43277.x · Cited by 777 · cited 1×
“Fosfomycin enters in bacteria using Hpt, the same transporter as hexoses-phosphate and glycerol-phosphate [108].”
BackgroundMulcahy, H., Charron-Mazenod, L., & Lewenza, S. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000213 · Cited by 711 · cited 5×
“The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation.”
BackgroundInfluentialMizuno, T., Chou, M. Y., & Inouye, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1966 · Cited by 695 · cited 1×
“On top of this regulation, there are two small antisense RNAs (micF [79] and micC [80]) which participate in the post-transcriptional regulation of OmpF and OmpC, respectively.”
BackgroundMutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694 · cited 1×
“view, the acquisition of a resistance phenotype requires a genetic change; either mutations (including point mutations, deletions and insertions), or the acquisition by horizontal gene transfer of antibiotic resistance genes [1–5].”
BackgroundAntibiotics as intermicrobial signaling agents instead of weapons
Linares, J. F., Gustafsson, I., Baquero, F., & Martinez, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608949103 · Cited by 658 · cited 1×
“bacterial populations [44,45], suggesting that antibiotics can induce transient, non-specific resistance to themselves.”
BackgroundContribution of bacterial outer membrane vesicles to innate bacterial defense
Manning, A. J., & Kuehn, M. J. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-258 · Cited by 622 · cited 2×
“initial defense mechanism against different environmental stresses including antibiotics [73].”
BackgroundGenes acrA and acrB encode a stress‐induced efflux system of Escherichia coli
Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., & Hearst, J. E. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02390.x · Cited by 602 · cited 1×
“or fatty acids [97–101], because bacteria can encounter these compounds and therefore might display a phenotype of transient resistance in the course of an infection.”
BackgroundKussell, E., Kishony, R., Balaban, N. Q., & Leibler, S. (2005) · Genetics · doi:10.1534/genetics.104.035352 · Cited by 584
Breeding latitude drives individual schedules in a trans-hemispheric migrant bird
Conklin, J. R., Battley, P. F., Potter, M. A., & Fox, J. W. (2010) · Nature Communications · doi:10.1038/ncomms1072 · Cited by 582
Mechanisms of RND multidrug efflux pumps
Nikaido, H., & Takatsuka, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.004 · Cited by 555 · cited 1×
“different, including antibiotics [85–90].”
The superficial life of microbes
Kolter, R., & Greenberg, E. P. (2006) · Nature · doi:10.1038/441300a · Cited by 555 · cited 1×
“Although most studies on bacterial susceptibility to antibiotics are performed using bacteria growing planktonically, microorganisms can grow forming biofilms when they are attached to a surface [32–35].”
BackgroundEvolution of species interactions in a biofilm community
Hansen, S. K., Rainey, P. B., Haagensen, J. A. J., & Molin, S. (2007) · Nature · doi:10.1038/nature05514 · Cited by 552 · cited 1×
“Although most studies on bacterial susceptibility to antibiotics are performed using bacteria growing planktonically, microorganisms can grow forming biofilms when they are attached to a surface [32–35].”
BackgroundNon-inherited antibiotic resistance
Levin, B. R., & Rozen, D. E. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1445 · Cited by 542 · cited 3×
“More recently, it has been shown that eight hours after infection bacteria are in a resting situation [6],”
BackgroundInfluentialPersister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 520 · cited 1×
“These resting cells might be a subpopulation of persisters (see below) present in any biofilm [52].”
BackgroundFunctional role of bacterial multidrug efflux pumps in microbial natural ecosystems
Martinez, J. L., Sánchez, M. B., Martínez-Solano, L., Hernandez, A., Garmendia, L., Fajardo, A., & Alvarez-Ortega, C. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00157.x · Cited by 491
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486 · cited 1×
“aeruginosa biofilms [58], whilst it is not relevant in the case of planktonic cells.”
BackgroundLomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 460 · cited 1×
“Classical methods for improving the efficacy of antibiotics are mostly based on the development of permeabilizers and of inhibitors of mechanisms of resistance, mainly of antibiotic inactivating enzymes and of multidrug efflux pumps [9,140–142].”
MethodWu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446 · cited 1×
“aeruginosa infections [135,136].”
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443 · cited 3×
“McPhee, J.B.; Lewenza, S.; Hancock, R.E.W. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.”
BackgroundPenetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms
Singh, R., Ray, P., Das, A., & Sharma, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq257 · Cited by 422 · cited 1×
“capability to diffuse into the biofilm will differ depending on the structure of the antibiotic [48].”
BackgroundKorch, S. B., Henderson, T. A., & Hill, T. M. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03779.x · Cited by 399 · cited 1×
“coli [129].”
Shafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391 · cited 1×
“or fatty acids [97–101], because bacteria can encounter these compounds and therefore might display a phenotype of transient resistance in the course of an infection.”
BackgroundThe Neglected Intrinsic Resistome of Bacterial Pathogens
Fajardo, A., Martínez-Martín, N., Mercadillo, M., Galán, J. C., Ghysels, B., Matthijs, S., Cornelis, P., Wiehlmann, L., Tümmler, B., Baquero, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001619 · Cited by 367 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundInvestigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms
Suci, P. A., Mittelman, M. W., Yu, F. P., & Geesey, G. G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2125 · Cited by 357 · cited 1×
“The most obvious one is that biofilms are complex structures in which the free diffusion of compounds as antibiotics [46,47] is more difficult that in liquid cultures (planktonic cells).”
BackgroundA global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356 · cited 1×
“view, the acquisition of a resistance phenotype requires a genetic change; either mutations (including point mutations, deletions and insertions), or the acquisition by horizontal gene transfer of antibiotic resistance genes [1–5].”
BackgroundRegulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence
Rotem, E., Loinger, A., Ronin, I., Levin-Reisman, I., Gabay, C., Shoresh, N., Biham, O., & Balaban, N. Q. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004333107 · Cited by 355 · cited 1×
“can render non-uniform bacterial populations in which those cells containing high levels of toxin arrest their growth for long periods of time [39,130,131].”
BackgroundRani, S. A., Pitts, B., Beyenal, H., Veluchamy, R. A., Lewandowski, Z., Davison, W. M., Buckingham-Meyer, K., & Stewart, P. S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00107-07 · Cited by 340 · cited 1×
“It has been found that the aerobic regions of Pseudomonas aeruginosa biofilms are susceptible to quinolones and resistant to cationic peptides whereas the opposite occurs at the hypoxic regions [55].”
BackgroundPhylogeny of multidrug transporters
Saier, Jr., & Paulsen, I. T. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0246 · Cited by 333 · cited 1×
“account for 10% of all transporters in some bacterial species [91–93].”
BackgroundFernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Pratt, L. A., Hsing, W., Gibson, K. E., & Silhavy, T. J. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02532.x · Cited by 317 · cited 1×
“micF is known to respond to changes in osmolarity [81], temperature [82] and nutrient availability [83], and is the link to other regulatory networks such as the Mar-Sox-Rob regulon, which responds to salicylate [84].”
BackgroundNalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J., & Häussler, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1680-1688.2006 · Cited by 317 · cited 1×
“One of the compounds that inhibits biofilm formation is the macrolide azithromycin [59].”
BackgroundDistribution of Bacterial Growth Activity in Flow-Chamber Biofilms
Sternberg, C., Christensen, B. B., Johansen, T., Toftgaard Nielsen, A., Andersen, J. B., Givskov, M., & Molin, S. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.9.4108-4117.1999 · Cited by 311 · cited 1×
“The different metabolic situation of each subpopulation is highly dependent on the oxygen and nutrients availability, which is higher at the upper layers of the biofilm and lower at the deeper ones [53,54].”
BackgroundDynamics of intracellular bacterial replication at the single cell level
Helaine, S., Thompson, J. A., Watson, K. G., Liu, M., Boyle, C., & Holden, D. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000041107 · Cited by 308 · cited 1×
“coli through the SOS-mediated induction of the toxin TisB [132] and intracellular pathogens can present nondividing, persistent, subpopulations when growing inside their host cells [133].”
BackgroundMetabolic regulation of antibiotic resistance
Martínez, J. L., & Rojo, F. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00282.x · Cited by 304 · cited 2×
“their susceptibility to antibiotics [17].”
BackgroundRole of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli
Hansen, S., Lewis, K., & Vulić, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-08 · Cited by 300 · cited 2×
“Some works have shown that the knockout of genes coding for metabolic enzymes, such as ygfA that encodes an enzyme involved in folate biosynthesis or yigB, encoding a flavin mononucleotide phosphatase decreases persistence [126], whereas their overexpression, increases tolerance.”
BackgroundPethe, K., Sequeira, P. C., Agarwalla, S., Rhee, K., Kuhen, K., Phong, W. Y., Patel, V., Beer, D., Walker, J. R., Duraiswamy, J., et al. (2010) · Nature Communications · doi:10.1038/ncomms1060 · Cited by 292 · cited 1×
“tuberculosis in vivo and in vitro, is important for the development of novel anti-tuberculosis antibiotics [20].”
BackgroundP. aeruginosa Biofilms in CF Infection
Wagner, V. E., & Iglewski, B. H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8079-9 · Cited by 288
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundRegulation of polymyxin resistance and adaptation to low-Mg2+ environments
Groisman, E. A., Kayser, J., & Soncini, F. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7040-7045.1997 · Cited by 282
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals
Grant, S. S., Kaufmann, B. B., Chand, N. S., Haseley, N., & Hung, D. T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203735109 · Cited by 273 · cited 1×
“In line with this reasoning, the authors demonstrated that antibiotic clofazimine, which increases ROS, successfully eradicates the persister population [139].”
Chico-Calero, I., Suárez, M., González-Zorn, B., Scortti, M., Slaghuis, J., Goebel, W., The European Listeria Genome Consortium§, & Vázquez-Boland, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012363899 · Cited by 269 · cited 2×
“The Hpt transporter is controlled by the global regulator of virulence, PfrA, which is highly expressed during macrophage infection [107,109].”
BackgroundStructure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update
Blair, J. M., & Piddock, L. J. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.07.003 · Cited by 266
Forst, S., Delgado, J., & Inouye, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6052 · Cited by 265 · cited 1×
“osmolarity and controls at the transcriptional level the OmpF/OmpC ratio [77,78].”
BackgroundEvolutionary origins of multidrug and drug‐specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Marek, K. S., Pao, S. S., Ronald, A. S., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.265 · Cited by 263 · cited 1×
“account for 10% of all transporters in some bacterial species [91–93].”
BackgroundMcCune, R. M., & Tompsett, R. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.104.5.737 · Cited by 260 · cited 1×
“It has been stated as well that this low susceptibility is the cause for the need of using very long treatments for slow-growing bacteria as Mycobacterium leprae [27] or Mycobacterium tuberculosis [28].”
BackgroundMacfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254 · cited 1×
“aeruginosa, there are at least three two-component systems (PhoP-PhoQ [65,66], PmrA-PmrB [67], and ParS-ParR [68]) that”
BackgroundFunctional relationship between bacterial cell density and the efficacy of antibiotics
Udekwu, K. I., Parrish, N., Ankomah, P., Baquero, F., & Levin, B. R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn554 · Cited by 250 · cited 1×
“Using experimental approaches and mathematical modeling, it has been shown that most likely both situations are relevant for inoculumdependent antibiotic resistance [120], and that other processes can be important for this phenotype.”
BackgroundClement, S., Vaudaux, P., Francois, P., Schrenzel, J., Huggler, E., Kampf, S., Chaponnier, C., Lew, D., & Lacroix, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/432735 · Cited by 245 · cited 1×
“It has been suggested that the existence of drug indifferent, slow growing (or resting) cells can be the cause of relapse after antibiotic treatment that can be observed for some bacterial infections [25,26].”
BackgroundMöker, N., Dean, C. R., & Tao, J. (2010) · Journal of Bacteriology · doi:10.1128/jb.01231-09 · Cited by 245
MicC, a Second Small-RNA Regulator of Omp Protein Expression in Escherichia coli
Chen, S., Zhang, A., Blyn, L. B., & Storz, G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.20.6689-6697.2004 · Cited by 243 · cited 1×
“On top of this regulation, there are two small antisense RNAs (micF [79] and micC [80]) which participate in the post-transcriptional regulation of OmpF and OmpC, respectively.”
BackgroundBrook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria
Poole, K. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.02.004 · Cited by 238 · cited 1×
“For example, it has been described that oxidative and nitrosidative stress [102] might alter the expression of multidrug efflux pumps.”
BackgroundTamae, C., Liu, A., Kim, K., Sitz, D., Hong, J., Becket, E., Bui, A., Solaimani, P., Tran, K. P., Yang, H., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.01982-07 · Cited by 234 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundDelihas, N., & Forst, S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5029 · Cited by 220
Multidrug efflux pumps and resistance: regulation and evolution
Paulsen, I. T. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.005 · Cited by 220 · cited 1×
“Expression of efflux pumps is usually tightly down-regulated, which means that transient expression is achieved just in the presence of the right effectors [94,95].”
BackgroundNikaido, E., Yamaguchi, A., & Nishino, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804544200 · Cited by 218 · cited 1×
“or fatty acids [97–101], because bacteria can encounter these compounds and therefore might display a phenotype of transient resistance in the course of an infection.”
BackgroundLetting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?
Chao, M. C., & Rubin, E. J. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134043 · Cited by 214 · cited 1×
“tuberculosis cells are resistant to isoniazid, but susceptible to metronidazol [29–31].”
BackgroundNonuniform spatial patterns of respiratory activity within biofilms during disinfection
Huang, C. T., Yu, F. P., McFeters, G. A., & Stewart, P. S. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.6.2252-2256.1995 · Cited by 210 · cited 1×
“The different metabolic situation of each subpopulation is highly dependent on the oxygen and nutrients availability, which is higher at the upper layers of the biofilm and lower at the deeper ones [53,54].”
BackgroundMacfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209 · cited 1×
“aeruginosa, there are at least three two-component systems (PhoP-PhoQ [65,66], PmrA-PmrB [67], and ParS-ParR [68]) that”
BackgroundBile Salts Modulate Expression of the CmeABC Multidrug Efflux Pump in Campylobacter jejuni
Lin, J., Cagliero, C., Guo, B., Barton, Y.-W., Maurel, M.-C., Payot, S., & Zhang, Q. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.21.7417-7424.2005 · Cited by 191 · cited 1×
“or fatty acids [97–101], because bacteria can encounter these compounds and therefore might display a phenotype of transient resistance in the course of an infection.”
BackgroundDaptomycin Rapidly Penetrates a Staphylococcus epidermidis Biofilm
Stewart, P. S., Davison, W. M., & Steenbergen, J. N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-08 · Cited by 190 · cited 1×
“penetration of the antibiotics into the biofilm does not seem to be the key element for explaining the phenotype of resistance [51].”
BackgroundThe Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism
Chen, H., Hu, J., Chen, P. R., Lan, L., Li, Z., Hicks, L. M., Dinner, A. R., & He, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803391105 · Cited by 186 · cited 1×
“As a consequence, MexAB-OprM is overexpressed leading to transient antibiotic resistance [104].”
BackgroundMacrolides beyond the conventional antimicrobials: a class of potent immunomodulators
Giamarellos-Bourboulis, E. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.001 · Cited by 185 · cited 1×
“aeruginosa infections given its strong anti-QS and anti-biofilm activity [60,61].”
BackgroundMiller, P. F., & Sulavik, M. C. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02553.x · Cited by 171 · cited 1×
“As a consequence, the expression of the AcrAB-TolC multidrug efflux system is induced [103] and bacteria become transiently antibiotic resistant.”
BackgroundNovel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa
Schurek, K. N., Marr, A. K., Taylor, P. K., Wiegand, I., Semenec, L., Khaira, B. K., & Hancock, R. E. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00507-08 · Cited by 169 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundAlvarez-Ortega, C., Wiegand, I., Olivares, J., Hancock, R. E. W., & Martínez, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00257-10 · Cited by 164 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundGefen, O., Gabay, C., Mumcuoglu, M., Engel, G., & Balaban, N. Q. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711712105 · Cited by 162 · cited 1×
“On the contrary, the fact that Type I persisters are fully susceptible to antibiotics in a short time window after the beginning of growth of the whole population indicates that persistence consists on a metabolic shift that occurs after the stationary phase is over [128].”
BackgroundTranscription Regulation of ompF and ompC by a Single Transcription Factor, OmpR
Yoshida, T., Qin, L., Egger, L. A., & Inouye, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602112200 · Cited by 162
Breidenstein, E. B. M., Khaira, B. K., Wiegand, I., Overhage, J., & Hancock, R. E. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00222-08 · Cited by 160 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundWhy are bacteria refractory to antimicrobials?
Hogan, D. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00357-0 · Cited by 160 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundLee, E. H., & Shafer, W. M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01530.x · Cited by 159 · cited 1×
“or fatty acids [97–101], because bacteria can encounter these compounds and therefore might display a phenotype of transient resistance in the course of an infection.”
BackgroundLinares, J. F., Moreno, R., Fajardo, A., Martínez‐Solano, L., Escalante, R., Rojo, F., & Martínez, J. L. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02292.x · Cited by 159 · cited 1×
“Altogether, these results indicate that the specific phenotype of susceptibility to antibiotics is under metabolic control and hence that changes in the bacterial metabolism can consequently alter the susceptibility to antibiotics [17,18].”
BackgroundBinding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa
Peterson, A. A., Hancock, R. E., & McGroarty, E. J. (1985) · Journal of Bacteriology · doi:10.1128/jb.164.3.1256-1261.1985 · Cited by 157 · cited 1×
“The LPS presents anionic groups where the cationic antibiotics bind, representing the first step of antibiotic uptake [64].”
BackgroundPersistence: mechanisms for triggering and enhancing phenotypic variability
Balaban, N. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.10.001 · Cited by 156 · cited 1×
“However, the situation is more complex [125], with a number of global regulators and metabolic enzymes involved in the process [126,127].”
BackgroundCharacterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Fernández, L., Álvarez-Ortega, C., Wiegand, I., Olivares, J., Kocíncová, D., Lam, J. S., Martínez, J. L., & Hancock, R. E. W. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-12 · Cited by 154 · cited 1×
“Some recent works have analyzed the determinants that contribute to the intrinsic resistance (intrinsic resistome) of bacterial pathogens [8–16].”
BackgroundMcDERMOTT, W. (1958) · PubMed Central · Cited by 152
Ecology and evolution of antibiotic resistance
Baquero, F., Alvarez‐Ortega, C., & Martinez, J. L. (2009) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2009.00053.x · Cited by 148 · cited 1×
“view, the acquisition of a resistance phenotype requires a genetic change; either mutations (including point mutations, deletions and insertions), or the acquisition by horizontal gene transfer of antibiotic resistance genes [1–5].”
BackgroundRipio, M. T., Brehm, K., Lara, M., Suárez, M., & Vázquez-Boland, J. A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7174-7180.1997 · Cited by 137 · cited 1×
“The Hpt transporter is controlled by the global regulator of virulence, PfrA, which is highly expressed during macrophage infection [107,109].”
BackgroundFraud, S., & Poole, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01495-10 · Cited by 137 · cited 2×
“A similar response to oxidative and nitrosidative stress has been described for other P. aeruginosa efflux pumps, like MexXY-OprM [105], and MexEF-OprN [106].”
Fetar, H., Gilmour, C., Klinoski, R., Daigle, D. M., Dean, C. R., & Poole, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-10 · Cited by 134 · cited 2×
“A similar response to oxidative and nitrosidative stress has been described for other P. aeruginosa efflux pumps, like MexXY-OprM [105], and MexEF-OprN [106].”
Comparative genomics of microbial drug efflux systems.
Paulsen, I. T., Chen, J. W., Nelson, W. C., & Saier, M. H. (2001) · PubMed · Cited by 132
Moreno, R., Martínez-Gomáriz, M., Yuste, L., Gil, C., & Rojo, F. (2009) · PROTEOMICS · doi:10.1002/pmic.200800918 · Cited by 132 · cited 1×
“aeruginosa [110–113].”
Morales, G., Linares, J. F., Beloso, A., Albar, J. P., Martínez, J. L., & Rojo, F. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1337-1344.2004 · Cited by 132 · cited 1×
“aeruginosa [110–113].”
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
Bull, J. J., Levin, B. R., DeRouin, T., Walker, N., & Bloch, C. A. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-35 · Cited by 127 · cited 1×
“Further works using a model in which mice were infected with a mixture of susceptible and resistant bacteria showed that during infection bacteria become increasingly refractory to treatment [24].”
MethodThe intrinsic resistome ofPseudomonas aeruginosato β-lactams
Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Hancock, R. E. W., & Martínez, J. L. (2011) · Virulence · doi:10.4161/viru.2.2.15014 · Cited by 123
Hernández, A., Ruiz, F. M., Romero, A., & Martínez, J. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002103 · Cited by 118 · cited 1×
“maltophilia [96].”
Drugs in Development for Tuberculosis
Ginsberg, A. M. (2010) · Drugs · doi:10.2165/11538170-000000000-00000 · Cited by 113 · cited 1×
“tuberculosis cells are resistant to isoniazid, but susceptible to metronidazol [29–31].”
BackgroundAntimicrobial Penetration and Efficacy in an In Vitro Oral Biofilm Model
Corbin, A., Pitts, B., Parker, A., & Stewart, P. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-11 · Cited by 113 · cited 1×
“The most obvious one is that biofilms are complex structures in which the free diffusion of compounds as antibiotics [46,47] is more difficult that in liquid cultures (planktonic cells).”
BackgroundThe accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli
Mortimer, P. G. S., & Piddock, L. J. V. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.2.195 · Cited by 107 · cited 3×
“the antibiotic and consequently renders resistance [75].”
BackgroundKim, J.-S., Heo, P., Yang, T.-J., Lee, K.-S., Cho, D.-H., Kim, B. T., Suh, J.-H., Lim, H.-J., Shin, D., Kim, S.-K., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00708-11 · Cited by 106 · cited 1×
“Following the same approach, it has been found that the addition of 3-[4-(4-methoxyphenyl)piperazin-1-yl]piperidin-4-yl biphenyl-4-carboxylate to bacterial cultures causes the reversion of persisters to antibiotic-sensitive cells [138].”
BackgroundTranscriptional regulation of multidrug efflux pumps in bacteria
Grkovic, S., Brown, M. H., & Skurray, R. A. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0248 · Cited by 103 · cited 1×
“Expression of efflux pumps is usually tightly down-regulated, which means that transient expression is achieved just in the presence of the right effectors [94,95].”
BackgroundMoreno, R., Marzi, S., Romby, P., & Rojo, F. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp825 · Cited by 99 · cited 1×
“aeruginosa [110–113].”
Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli
Reguera, J. A., Baquero, F., Pérez-Díaz, J. C., & Martínez, J. L. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.5.569 · Cited by 97 · cited 2×
“In the case of bacteria producing antibiotic-inactivating enzymes, this effect is due to the activity of the enzyme that degrades the antibiotic at higher rates when more cells are present [116,117,119].”
BackgroundMacGregor, C. H., Wolff, J. A., Arora, S. K., & Phibbs, P. V. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.22.7204-7212.1991 · Cited by 86 · cited 1×
“aeruginosa [110–113].”
Pan, J., Bahar, A. A., Syed, H., & Ren, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045778 · Cited by 80 · cited 1×
“However, the effect is not due to the inhibition of QS and the mechanisms for this activity remain to be fully determined [137].”
BackgroundNoninherited Resistance to Antibiotics
Levin, B. R. (2004) · Science · doi:10.1126/science.1103077 · Cited by 79
Biofilm Induced Tolerance towards Antimicrobial Peptides
Folkesson, A., Haagensen, J. A. J., Zampaloni, C., Sternberg, C., & Molin, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001891 · Cited by 78 · cited 1×
“Different works have shown that bacteria forming biofilms are less susceptible to antibiotics than those growing planktonically [36–43].”
BackgroundGellatly, S. L., Needham, B., Madera, L., Trent, M. S., & Hancock, R. E. W. (2012) · Infection and Immunity · doi:10.1128/iai.00382-12 · Cited by 69 · cited 1×
“resistance by host-defense peptides belonging to innate human defense [70], and for the new peptides”
BackgroundSynergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm
Dong, Y., Chen, S., Wang, Z., Peng, N., & Yu, J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks490 · Cited by 63 · cited 1×
“Increasing the diffusion of the antibiotics inside biofilms might thus help in enhancing their activity [49].”
BackgroundRole of the mar-sox-rob Regulon in Regulating Outer Membrane Porin Expression
Chubiz, L. M., & Rao, C. V. (2011) · Journal of Bacteriology · doi:10.1128/jb.01382-10 · Cited by 61 · cited 1×
“micF is known to respond to changes in osmolarity [81], temperature [82] and nutrient availability [83], and is the link to other regulatory networks such as the Mar-Sox-Rob regulon, which responds to salicylate [84].”
BackgroundEagle, H. (1949) · Journal of Experimental Medicine · doi:10.1084/jem.90.6.595 · Cited by 58 · cited 1×
“In fact, it has been described that the antibiotic concentrations required for curing an infection are directly related to the duration of the infection [23].”
BackgroundMultilevel population genetics in antibiotic resistance
Baquero, F., & Coque, T. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00293.x · Cited by 48 · cited 1×
“view, the acquisition of a resistance phenotype requires a genetic change; either mutations (including point mutations, deletions and insertions), or the acquisition by horizontal gene transfer of antibiotic resistance genes [1–5].”
BackgroundLee, S. W., Foley, E. J., & Epstein, J. A. (1944) · Journal of Bacteriology · doi:10.1128/jb.48.4.393-399.1944 · Cited by 47
Soriano, F. G., Ponte, C., Santamaría, M., & Jimenez-Arriero, M. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.621 · Cited by 43 · cited 1×
“It has been suggested that this effect can be the cause of the failure for treating infections with a high bacterial load, because the actual minimal inhibitory concentrations of such bacterial populations are higher than those determined using classical laboratory tests [115,118].”
Backgroundβ-Lactamase induction and cell wall recycling in gram-negative bacteria
Wiedemann, B., Pfeifle, D., Wiegand, I., & Janas, E. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80002-2 · Cited by 35 · cited 1×
“Although increased resistance can also be achieved because of the induction of specific resistance mechanisms (for instance induction of chromosomally-encoded -lactamases by -lactams [7]), this topic is not usually considered as phenotypic resistance and will not be discussed in the article.”
BackgroundRahmati-Bahram, A., Magee, J. T., & Jackson, S. K. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.4.665 · Cited by 34 · cited 1×
“A similar phenomenon of LPS modification leading to transient resistance to aminoglycosides has been described in Stenotrophomonas maltophilia [72].”
BackgroundThe Antibiotic Resistome: Challenge And Opportunity For Therapeutic Intervention
Martínez, J. L. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.2 · Cited by 30 · cited 2×
“Classical methods for improving the efficacy of antibiotics are mostly based on the development of permeabilizers and of inhibitors of mechanisms of resistance, mainly of antibiotic inactivating enzymes and of multidrug efflux pumps [9,140–142].”
BackgroundMethodEcological and Temporal Constraints in the Evolution of Bacterial Genomes
Boto, L., & Martínez, J. L. (2011) · Genes · doi:10.3390/genes2040804 · Cited by 27 · cited 1×
“view, the acquisition of a resistance phenotype requires a genetic change; either mutations (including point mutations, deletions and insertions), or the acquisition by horizontal gene transfer of antibiotic resistance genes [1–5].”
BackgroundBacterial persistence in leprosy.
Toman, K. (1981) · PubMed · Cited by 21
Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance
Reguera, J. A., Baquero, F., Pérez-Díaz, J. C., & Martínez, J. L. (1988) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975047 · Cited by 19 · cited 1×
“In the case of bacteria producing antibiotic-inactivating enzymes, this effect is due to the activity of the enzyme that degrades the antibiotic at higher rates when more cells are present [116,117,119].”
BackgroundAre Nonlethal Targets Useful for Developing Novel Antimicrobials?
Martínez, J. L., Rojo, F., & Vilà, J. (2011) · Future Microbiology · doi:10.2217/fmb.11.47 · Cited by 18
Non-canonical mechanisms of antibiotic resistance
Martínez, J. L., Blázquez, J., & Baquero, F. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111820 · Cited by 18 · cited 1×
“It has been suggested that this effect can be the cause of the failure for treating infections with a high bacterial load, because the actual minimal inhibitory concentrations of such bacterial populations are higher than those determined using classical laboratory tests [115,118].”
BackgroundTakayanagi, K., Maeda, S., & Mizuno, T. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04385.x · Cited by 15 · cited 1×
“micF is known to respond to changes in osmolarity [81], temperature [82] and nutrient availability [83], and is the link to other regulatory networks such as the Mar-Sox-Rob regulon, which responds to salicylate [84].”
BackgroundFitoussi, F., Cohen, R., Brami, G., Doit, C., Brahimi, N., ROCQUE, F. D. L., & Bingen, É. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01709587 · Cited by 14 · cited 1×
“It has been suggested that the existence of drug indifferent, slow growing (or resting) cells can be the cause of relapse after antibiotic treatment that can be observed for some bacterial infections [25,26].”
BackgroundInfluence of gene dosing on antibiotic resistance mediated by inactivating enzymes.
Martínez, J. L., Blázquez, J., Mf, V., Martínez-Ferrer, M., Ja, R., Culebras, E., & Baquero, F. (1989) · PubMed · Cited by 4
Cited by
Role of bacterial efflux pumps in biofilm formation
Alav, I., Sutton, J. M., & Rahman, K. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky042 · Cited by 504
Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria
Peng, B., Su, Y.-B., Li, H., Han, Y., Guo, C., Tian, Y.-M., & Peng, X.-X. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.008 · Cited by 481
“Treating Clinically Relevant Bacterial Biofilms and Persisters Infection with bacterial biofilms and persisters are a significant concern in the clinical environment (Cohen et al., 2013; Corona and Martinez, 2013; Drenkard and Ausubel, 2002); therefore, it would be clinically useful if biofilms and persisters were sus…”
BackgroundWang, X., Biswas, S., Paudyal, N., Pan, H., Li, X., Fang, W., & Yue, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00985 · Cited by 277
“AR can also be achieved by biofilm production which can cause increased risk of food safety (Steenackers et al., 2012; Corona and Martinez, 2013).”
BackgroundRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Kurenbach, B., Marjoshi, D., Amábile-Cuevas, C. F., Ferguson, G. C., Godsoe, W., Gibson, P., & Heinemann, J. A. (2015) · mBio · doi:10.1128/mbio.00009-15 · Cited by 206
“This form of adaptive resistance is usually a species-uniform response that occurs only in environments that induce relevant changes in gene expression (12).”
Metadata
- Authors
- Corona, F., & Martinez, J.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Centro Nacional de Biotecnología, CSIC, Darwin 3, 28049-Madrid, Spain
- ORCID
- Martinez, Jose
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2013-04-18
- Volume
- 2
- Issue
- 2
- Pages
- 237-255
- ISSN
- 2079-6382 (ISSN-L)
- PMC
- PMC4790337
- OpenAlex
- W2086293991
- Cited by
- 205
- References
- 143
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 24 · 2023: 30 · 2022: 27 · 2021: 20 · 2020: 17 · 2019: 17 · 2018: 12 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 1
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antibiotics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission (241476, 282004)
- Ministerio de Ciencia e Innovación (BIO2011-25255)
- Instituto de Salud Carlos III
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- phenotypic antibiotic resistance, biofilm, bacterial persistence, stationary phase, bacterial metabolism, antimicrobial susceptibility testing, pathogenic bacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.